Literature DB >> 41247

Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes.

J P Vincent, B Kartalovski, P Geneste, J M Kamenka, M Lazdunski.   

Abstract

[3H]Phencyclidine binds to synaptic membranes from rat brain in a saturable, reversible, and selective fashion, with a dissociation constant Kd of 0.25 microM and a maximal binding capacity of 2.4 pmol/mg of membrane protein--i.e., 250 pmol/g of brain. The binding activity is concentrated in synaptosomal fractions, is higher in cerebral cortex and corpus striatum than in other parts of the rat brain, and is not detectable in the spinal cord. Only molecules of the phencyclidine series and ketamine are able to bind to the phencyclidine receptor. [3H]Phencyclidine bound to its receptor is not displaced by the classical neurotransmitters or neuromodulators. There is a good correlation between the apparent affinities of a series of phencyclidine analogs for the phencyclidine receptor and the pharacological activities of these analogs as measured by the rotarod assay.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41247      PMCID: PMC411644          DOI: 10.1073/pnas.76.9.4678

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Observations on the psychotomimetic effects of Sernyl.

Authors:  C B BAKKER; F B AMINI
Journal:  Compr Psychiatry       Date:  1961-10       Impact factor: 3.735

2.  Study of a new schizophrenomimetic drug; sernyl.

Authors:  E D LUBY; B D COHEN; G ROSENBAUM; J S GOTTLIEB; R KELLEY
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-03

3.  A study of a 1-aryl cyclo hexyl amine for anesthesia.

Authors:  F E GREIFENSTEIN; M DEVAULT; J YOSHITAKE; J E GAJEWSKI
Journal:  Anesth Analg       Date:  1958 Sep-Oct       Impact factor: 5.108

4.  Sernyl (CI-395) in clinical anaesthesia.

Authors:  M JOHNSTONE; V EVANS; S BAIGEL
Journal:  Br J Anaesth       Date:  1959-10       Impact factor: 9.166

5.  The opiate receptor and opoid peptides.

Authors:  S H Snyder; R Simantov
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

6.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

7.  Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action.

Authors:  A B Young; S R Zukin; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

8.  Phencyclidine and ketamine: comparison with the effect of cocaine on the noradrenergic neurones of the rat brain cortex.

Authors:  H D Taube; H Montel; G Hau; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Muscarinic cholinergic binding in rat brain.

Authors:  H I Yamamura; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

View more
  39 in total

1.  Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.

Authors:  T Taşkin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  The molecular structure of opiate receptors.

Authors:  M Wollemann
Journal:  Neurochem Res       Date:  1987-02       Impact factor: 3.996

3.  Phencyclidine is a negative allosteric modulator of signal transduction at two subclasses of excitatory amino acid receptors.

Authors:  J T Wroblewski; F Nicoletti; E Fadda; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Inhibition of (+)[3H]SKF 10,047 binding to rat brain membranes by FAB fragments from a monoclonal antibody directed against the opioid receptor.

Authors:  C B Tyler; J M Bidlack
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

5.  A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice.

Authors:  G E Evoniuk; R P Hertzman; P Skolnick
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.

Authors:  E T Iwamoto
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Phencyclidine-analogue self-injection by the baboon.

Authors:  S E Lukas; R R Griffiths; J V Brady; R M Wurster
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Phencyclidine ("angel dust") analogs and sigma opiate benzomorphans cause cerebral arterial spasm.

Authors:  B T Altura; R Quirion; C B Pert; B M Altura
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Involvement of opioid receptors in phencyclidine-induced enhancement of brain histamine turnover in mice.

Authors:  Y Itoh; R Oishi; M Nishibori; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.